Paracrine effects of endothelial cells in a diabetic mouse model: Capacitative calcium entry stimulated thromboxane release

Hormone and Metabolic Research

Volumn 40, Issue 9, 2008, Pages 645-650

  Okon, E B ^a,b   Colbabaie, A ^a   Van Breemen, C ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Mouse aorta; Ob ob mice; Sarcoplasmic endoplasmic reticulum ATPase; Thromboxane A2 receptor; Vasoconstriction

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; CALCIUM CHANNEL; CALCIUM ION; CYCLOPIAZONIC ACID; INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR; THAPSIGARGIN; THROMBOXANE; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; C57BL 6 MOUSE; CALCIUM TRANSPORT; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; EXTRACELLULAR CALCIUM; FORCE; MALE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; TRANSPORT KINETICS; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; AORTA; CALCIUM SIGNALING; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; INDOLES; INDOMETHACIN; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MODELS, BIOLOGICAL; NG-NITROARGININE METHYL ESTER; PARACRINE COMMUNICATION; THROMBOXANES; VASOCONSTRICTION;

MUS;

EID: 53649109982     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1083812     Document Type: Article

References (16)

1. Casiglia E, Zanette G, Mazza A, Donadon V, Donada C, Pizziol A, Tikhonoff V, Palatini P, Pessina AC. Cardiovascular mortality in non-insulindependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects. EurJ Epidemiol 2000; 16: 677-684
2. Mikhailidis DP, Press M. The importance of treating multiple cardiometabolic risk factors in patients with Type 2 diabetes. Expert Opin Pharmacother 2007; 8: 3009-3020
3. Okon EB, Szado T, Laher I, MacManus B, Breemen C van. Augmented contractile response of vascular smooth muscle in a diabetic mouse model. J Vasc Res 2003; 40: 520-530
4. Okon EB, Chung AW, Rauniyar P, Padilla E, Tejerina T, MacManus BM, Luo H, Breemen C van. Compromised arterial function in human type 2 diabetic patients. Diabetes 2005; 54: 2415-2423
5. Levy J, Gavin JR 3rd, Sowers JR. Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med 1994; 96: 260-273
6. Okon EB, Colbabaie A. Breemen C van. In the presence of L-NAME SERCA blockade induces endothelium-dependent contraction of mouse aorta through activation of smooth muscle prostaglandin H2/thromboxane A2 receptors. Br J Pharmacol 2002; 137: 545-553
7. Ma HT, Patterson RL, Rossum DB van, Birnbaumer L, Mikoshiba K, Gill DL. Requirement of the inositol triphosphate receptor for activation of store-operated Ca2+channels. Science 2000; 287: 1647-1651
8. Taddei S, Vanhoutte PM. Endothelium-dependent contractions to endothelin in the rat aorta are mediated by thromboxane A2. J Cardiovasc Pharmacol 1993; 22: S328-S331
9. Catar RA, Müller G, Heidler J, Schmitz G, Bornstein SR, Morawietz H. Low-density lipoproteins induce the renin-angiotensin system and their receptors in human endothelial cells. Horm Metab Res 2007; 39: 801-805
10. 2+ distribution. Diabetes 1999; 48: 1323-1330
11. Tooke JE, Hannemann MM. Adverse endothelial function and the insulin resistance syndrome. J Intern Med 2000; 247: 425-431
12. Tesfamariam B, Jakubowski JA, Cohen RA. Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TxA2. Am J Physiol 1989; 257: H1327-H1333
13. Percy V, Taylor SG. A comparison of spasmogenic and relaxant responses in aortae from C57/BL/KsJ diabetic mice with those from their non-diabetic litter mates. Pharmacology 1998; 56: 267-275
14. Rudofsky G, Reismann P. Grafe IA, Konrade I, Djuric Z, Tafel J, Buchbinder S, Zorn M, Humpert PM, Hamann A, Morcos M, Nawroth PP, Bierhaus A. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-κB binding activity. Horm Metab Res 2007; 39: 665-671
15. Napoli E, Franco N. Thromboxane A2 production in the pathogenesis of diabetic complications. Minerva Endocrinol 1998; 23: 1-5
16. Lasserre B, Navarro-Delmasure C, Pham Huu Chanh A, Catala J, Hollande E. Modifications in the TXA (2) and PG1 (2) plasma levels and some other biochemical parameters during the initiation and development of non-insulin-dependent diabetes mellitus (NIDDM) syndrome in the rabbit. Prostag Leukot Essent Fatty Acids 2000; 62: 285-291